<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03845738</url>
  </required_header>
  <id_info>
    <org_study_id>C-AS-18-001</org_study_id>
    <nct_id>NCT03845738</nct_id>
  </id_info>
  <brief_title>Retrospective Evaluation of Clinical Performance of the Astra Tech Implant System EV When Used in Everyday Practice</brief_title>
  <official_title>Retrospective Evaluation of Clinical Performance of the Astra Tech Implant System EV When Used in Everyday Practice</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dentsply Sirona Implants</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dentsply Sirona Implants</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed as a retrospective, multi-center study. The study population consist
      of subjects who received one or more OsseoSpeed EV implants during the period January 1st
      2015 to December 31st 2016. Two hundred subjects will be enrolled, approximately 25-30
      subjects per site. The study includes retrospective data collection from subjects' medical
      records and data collection from one prospective study visit with a clinical examination.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 12, 2019</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percent of survived implants at time of the follow-up visit</measure>
    <time_frame>Minimum of 2 years of use up to a maximum of around 4½ years of use</time_frame>
    <description>Survival defined as implant in situ at time of the follow-up visit. Primary analysis will be performed on implant level.</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Dental Implants</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OsseoSpeed EV implant</intervention_name>
    <description>The investigational product (OsseoSpeed EV implant) is already included in a restoration in the subject at enrollment, thus this study does not involve the installation of any investigational products.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will consist of individuals who received OsseoSpeed EV implants,
        during January 1st 2015 to December 31st 2016, as part of a prosthetic restoration
        replacing one or more teeth, in any position in the mouth.

        The results from this study should be representative for the general population, therefore
        there will be no subject related restrictions regarding which subjects to include in the
        study population (except that the subjects needs to be at least 18 years old at time of
        implant installation).
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject ≥ 18 years at time of implant installation.

          -  Subject signed and dated the informed consent form.

          -  Having installed one or more OsseoSpeed EV implants between January 1st 2015 and
             December 31st 2016.

        Exclusion Criteria:

          -  Unlikely to be able to comply with study procedures, according to Investigator's
             judgement.

          -  Subject is not willing to participate in the study or not able to understand the
             content of the study.

          -  Involvement in the planning or conduct of the study.

          -  Simultaneous participation in another clinical study that may interfere with the
             present study.

          -  Severe non-compliance to CIP as judged by the Investigator and/or Dentsply Sirona
             Implants.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stijn Vervaeke, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centrum voor tandheelkunde Geluwe, Belgium</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ulrika Bonander</last_name>
    <phone>+46313763500</phone>
    <email>ulrika.bonander@dentsplysirona.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Illinois College of Dentistry</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>660612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lyndon Cooper, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centrum voor tandheelkunde Geluwe</name>
      <address>
        <city>Geluwe</city>
        <zip>8940</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stijn Vervaeke, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Burlington Prosthodontics</name>
      <address>
        <city>Burlington</city>
        <zip>ON L7S 1T8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Oliver C. Pin-Harry, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oral Hammaslääkärit</name>
      <address>
        <city>Helsinki</city>
        <zip>00250</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patricia Stoor, Ass. Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Implantarium Gernsbach</name>
      <address>
        <city>Gernsbach</city>
        <zip>765 93</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Steveling Helmut, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik Heidelberg, Klinik und Poliklinik für Mund-, Kiefer- und Gesichtschirurgie</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Mertens, Ass. Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hallands sjukhus Halmstad, Department of Oral &amp; Maxillofacial surgery</name>
      <address>
        <city>Halmstad</city>
        <zip>301 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter Abrahamsson, Dr.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Finland</country>
    <country>Germany</country>
    <country>Sweden</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>February 18, 2019</study_first_submitted>
  <study_first_submitted_qc>February 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 19, 2019</study_first_posted>
  <last_update_submitted>January 28, 2020</last_update_submitted>
  <last_update_submitted_qc>January 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>OsseoSpeed</keyword>
  <keyword>EV</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

